Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 2.75% | 309.79 | 0.0% | $5214.82m | |
| BNTX | BioNTech SE | 2.65% | 342.31 | 0.0% | $1573.28m | |
| NVAX | Novavax, Inc. | -1.57% | 159.42 | 78.2% | $844.03m | |
| AMGN | Amgen, Inc. | 0.43% | 202.04 | 1.4% | $595.81m | |
| GILD | Gilead Sciences, Inc. | -0.34% | 69.43 | 1.0% | $508.03m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.95% | 202.51 | 1.9% | $474.46m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.35% | 625.45 | 2.7% | $467.64m | |
| LGVN | Longeveron Inc. | 16.11% | 20.90 | 0.0% | $416.81m | |
| ILMN | Illumina, Inc. | -3.49% | 345.01 | 3.3% | $313.91m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -3.74% | 4.12 | 0.7% | $288.00m | |
| BIIB | Biogen, Inc. | -2.80% | 222.11 | 1.8% | $271.16m | |
| OCGN | Ocugen, Inc. | -9.27% | 5.73 | 0.0% | $192.28m | |
| INCY | Incyte Corp. | -1.88% | 65.38 | 2.4% | $153.30m | |
| EXAS | EXACT Sciences Corp. | -5.55% | 76.10 | 18.0% | $147.39m | |
| SGEN | Seagen Inc. | -5.56% | 149.85 | 5.8% | $142.97m |
Company Profile
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.